SpringHill Suites NY Manhattan Times Square South, New York, NY
Jonathan Roses will lead a session titled “Patents and Related IP Protections and Mechanisms” at the 42nd annual FDA Boot Camp presented by the American Conference Institute ...
Jeff Hsi will present at the annual Comparative Patent Practice Conference in Tokyo, Japan. Among Jeff’s upcoming presentations are: “Clinical Trials as Prior Art”, ...
Jonathan Roses will lead a workshop with Emily Whelan of WilmerHale titled “Hatch-Waxman and BPCIA in the Trenches: Exclusivity and Bioequivalency Working Group” at the 41st ...
Wolf Greenfield is proud to co-host a webinar titled "Considerations for Patent Term Extensions / SPCs in the USA, Europe, and Japan" with SHIGA and HGF. Jeff Hsi will serve as a ...
Flight Club Boston l 60 Seaport Blvd, Suite 215, Boston, MA 02210
Wolf Greenfield is pleased to welcome clients and colleagues to our home city for the BIO International Convention! Please join us in Boston's beautiful Seaport District, just a ...
Boston Bar Association, 16 Beacon Street, Boston, MA
Chelsea Loughran will speak on a panel about Intellectual Property in Life Sciences at the Boston Bar Association’s 2023 Annual IP Year in Review on March 23.
On Friday, December 2nd, Jean Ge, Jeff Hsi, Tim Oyer, Patrick Waller, and Dan Young presented “Patent Lifecycle Management and Antibody Patenting” to ASTAR.
Jeff Hsi will present at the annual Comparative Patent Practice Conference in Tokyo, Japan. Jeff will present a talk titled “Clinical Trials as Prior Art” followed by ...
Rob Sahr will speak during a session titled "Double Patenting, Double Trouble?: Continuations, Terminal Disclaimers, and Interplay with PTA and PTE" at the First Annual Life ...
Jonathan Roses will present a virtual panel titled "Examining the Current Drug Exclusivity Landscape in Europe: Implementing the Latest Strategies for Effective Patent Lifecycle ...
Wolf Greenfield is proud to co-host a webinar titled "A Comparison of IP Practice in EU, US, and JP for New Medical Use and Method of Treatment Patenting" with SHIGA and HGF. Jeff ...
Kevin MacDonald will present on "Becoming 'Diligence-ready ' Implementation of IP Strategies for Early-Stage Gene Therapy Companies" during the Commercialization Strategies, ...
This workshop will build upon the content covered during the FDA Boot Camp main conference on the regulatory and IP interplay in the Hatch-Waxman and BPCIA schematics. Wolf ...